Company Update
Company Update
Company Update

Valink presents at Curious2024 Ignite Session

March 24, 2021

LiliumX is proud to graduate from the Y Combinator startup accelerator in their Winter 2021 batch. With an acceptance rate of approximately 1%, the renowned program provides initial funding and mentorship to promising start-ups. Y Combinator has successfully launched companies such as Ginkgo Bioworks, Airbnb, and Dropbox. The program provided valuable training resources, a wide network of other tech and biotech companies, as well as a $125,000 initial investment.

"We are grateful to be a part of the Y Combinator network, and have thoroughly enjoyed the 3-month remote program. Y Combinator was integral to LiliumX's early successes and has set a steep trajectory for the company."

- Arne Scheu, CEO of LiliumX

For more information, read TechCrunch's Y Combinator Winter 21 news coverage here or see LiliumX’s company overview at Y Combinator’s portfolio here.

Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
United States

Valink Therapeutics Inc
One Broadway,
Cambridge,
Massachusetts,
02142

United Kingdom

Valink Therapeutics Ltd
Imperial I-Hub,

84 Wood Lane,

London,

W12 0BZ